Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma, Follicular × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 8 Brain Neoplasms 5 Neoplasm Metastasis 3 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurocytoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adamantinoma 1

Interventions

lenvatinib 3 Sunitinib 3 cabozantinib 2 vandetanib 1 tremelimumab 1 tanespimycin 1 pembrolizumab 1 durvalumab 1 cediranib 1 Vorinostat 1 Sorafenib 1 Pharmacogenomic Testing 1 Lenalidomide 1 Iodine-131 1 Gefitinib 1 Bortezomib 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡